Patients with elevated levels of CSF glucose and plasma sICOSL, increased percentages of peripheral blood CD4+ICOS+ and CD19+PD-L1+, and symptoms of cognitive impairment were more likely to be diagnosed with AE. Here, CD19 is linked to Cognitive impairment.